TICKERNERD
Menu
OPCHOPCHHealthcare · Medical Care Facilities

OPCH Stock Forecast: Option Care Health, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$24
−0.52% on the day

The 13 Wall Street analysts covering Option Care Health, Inc. hold a median 12-month price target of $28 — +16.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 81 of 100 as at 13 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$3.6B
Ticker Nerd rank
81 / 100
Median analyst target
$28
Analysts covering
13
Total return, dividends reinvested
1W
+0.7%
1M
+12.2%
YTD
−24.8%
1Y
−15.7%
From 52W high
−34.6%
From 52W low
+22.7%
$20
$37
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

OPCH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Option Care Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
81 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
94
Revisions
89
Issuance
75
Accruals
71
Volatility
69
Quality
68
Growth
51
Size
28
Momentum
19

Value (94): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (19): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

OPCH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on OPCH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$25$30$35$40Oct 25Jan 26Apr 26Jul 26OPCHHigh $39Median $28Low $23

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says13 analysts
8 Buy5 Hold0 Sell
Low $23Median $28High $39

The green dot is the last close — the median target sits +16.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
30 July 2026Deutsche BankDowngradeHold$26 → $24
17 July 2026Stephens & Co.DowngradeEqual-Weight$30 → $24
17 July 2026Stephens & Co.DowngradeEqual-Weight—
8 June 2026Goldman SachsInitiatesNeutral$22
8 June 2026Goldman SachsInitiatesNeutral—
6 May 2026Morgan StanleyMaintainsOverweight—
4 May 2026JP MorganMaintainsOverweight—
1 May 2026Barrington ResearchMaintainsOutperform—
1 May 2026TD CowenMaintainsHold—
1 May 2026UBSMaintainsBuy—
16 Jan 2026Barrington ResearchMaintainsOutperform—
13 Jan 2026CitizensReiteratesMarket Outperform—
13 Jan 2026Morgan StanleyMaintainsOverweight—
11 Dec 2025Stephens & Co.InitiatesOverweight—
9 Dec 2025B of A SecuritiesMaintainsBuy—
9 Dec 2025Deutsche BankMaintainsBuy—
3 Nov 2025TD CowenMaintainsHold—
31 Oct 2025Barrington ResearchMaintainsOutperform—
31 Oct 2025CitizensMaintainsMarket Outperform—
17 Oct 2025Morgan StanleyInitiatesOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. OPCH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

OPCH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−3.0%
Analysts raising
0
Analysts cutting
1
Fundamentals

Option Care Health, Inc. (OPCH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
18.2×

Cheaper than 42% of US stocks

Price / sales
0.6×

Cheaper than 79% of US stocks

Price / book
2.9×

Cheaper than 36% of US stocks

EV / EBITDA
11.5×

Cheaper than 34% of US stocks

Growth & margins
Revenue growth (YoY)
1.9%

Higher than 32% of US stocks

Earnings growth (YoY)
6.7%

Higher than 44% of US stocks

Gross margin
18.5%

Higher than 19% of US stocks

Operating margin
5.9%

Higher than 57% of US stocks

Net margin
3.7%

Higher than 57% of US stocks

Returns & dividend
Return on equity
16.0%

Higher than 76% of US stocks

Return on assets
6.2%

Higher than 82% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

OPCH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
OPCHOption Care Health, Inc.$3.6B
81
NHCNational HealthCare Corp.$3.4B
68
CONConcentra Group Holdings Parent, Inc.$4.5B
95
BKDBrookdale Senior Living, Inc.$3.0B
76
LFSTLifestance Health Group, Inc.$4.7B
96
ACHCAcadia Healthcare Co., Inc.$2.8B
54
AVAHAveanna Healthcare Holdings, Inc.$2.5B
90

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Option Care Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest OPCH news & analysis

OPCH vs. PNTG: Which Stock Is the Better Value Option?

Zacks Investment Research · 7 Aug 2026neutral

Zacks Investment Research published an article comparing Option Care Health (OPCH) with The Pennant Group (PNTG), asking which of the two Medical - Outpatient and Home Healthcare stocks offers value investors a better opportunity. The piece frames the comparison as a question rather than reaching a conclusion.

Why it matters — The piece highlights that OPCH is being actively evaluated alongside a peer in the value-investing community, which is relevant context for those tracking the stock.

Madison Small Cap Fund Q2 2026 Portfolio Activity

Seeking Alpha · 6 Aug 2026negative

Madison Small Cap Fund reported its Q2 2026 portfolio activity, during which it sold three holdings, including its position in Option Care Health (OPCH), and added four new investments. The fund described the quarter as active for portfolio changes.

Why it matters — A prominent mutual fund decided to exit its OPCH position during the quarter, which could be relevant to investors tracking institutional interest in the stock.

Is Option Care Health (OPCH) Stock Undervalued Right Now?

Zacks Investment Research · 5 Aug 2026neutral

Zacks Investment Research published an article asking whether Option Care Health (OPCH) stock is currently undervalued. The piece outlines Zacks' approach, which centers on its Zacks Rank system that emphasizes earnings estimates and estimate revisions, while also tracking value, growth, and momentum trends to identify strong stocks.

Why it matters — OPCH watchers would care because the article signals that Zacks is actively evaluating OPCH's valuation, with investors likely to watch how Zacks' earnings-estimate-based ranking applies to the company.

Option Care Health, Inc. (OPCH) Q2 2026 Earnings Call Transcript

Seeking Alpha · 29 July 2026neutral

Option Care Health, Inc. held its Q2 2026 earnings conference call, during which management discussed the company's financial results and operational performance for the quarter.

Why it matters — The call provides OPCH investors with direct insight into the company's financial health, strategic direction, and management's perspective on recent performance.

Option Care Health Q2 Earnings Call Highlights

MarketBeat · 29 July 2026positive

Option Care Health reported second-quarter 2026 results that beat its internal expectations, with sequential improvements in revenue, adjusted EBITDA, and adjusted earnings per share. The company maintained its full-year revenue outlook while narrowing its adjusted EBITDA and EPS guidance ranges.

Why it matters — The results topped the company's own expectations and showed sequential improvement across key financial metrics, and the narrowed guidance ranges offer investors a clearer view of expected full-year performance.

FAQ

Frequently asked questions about OPCH stock

What is the OPCH stock price forecast for 2026-2027?

The 13 Wall Street analysts covering Option Care Health, Inc. have a median 12-month price target of $28, with estimates ranging from $23 to $39. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is OPCH stock a buy right now?

Of the 13 analysts covering Option Care Health, Inc., 8 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Option Care Health, Inc. 81 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank OPCH?

As at 13 Aug 2026, Option Care Health, Inc. ranks 81 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (94 of 100).

Will OPCH stock go up?

No one can know that. What the data says: the median 12-month target from 13 analysts implies +16.9% from the last close, and Ticker Nerd's factor model ranks Option Care Health, Inc. 81 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the OPCH stock forecast for 2030?

No analyst covering Option Care Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for OPCH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $23 to $39 over the next 12 months.

How has OPCH stock performed over the past year?

Option Care Health, Inc. returned -15.7% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Option Care Health, Inc. do?

Option Care Health Inc. operates as a healthcare services company, primarily engaged in providing infusion therapy and other related services.

What is the latest news on OPCH?

The most recent item we track (Zacks Investment Research, 7 Aug 2026): "OPCH vs. PNTG: Which Stock Is the Better Value Option?". Zacks Investment Research published an article comparing Option Care Health (OPCH) with The Pennant Group (PNTG), asking which of the two Medical - Outpatient and Home Healthcare stocks offers value investors a better opportunity. The piece frames the comparison as a question rather than reaching a conclusion.

Company

About Option Care Health, Inc.

Option Care Health Inc. operates as a healthcare services company, primarily engaged in providing infusion therapy and other related services. Its core function revolves around delivering comprehensive care through its network of facilities, home-based services, and care management programs. Option Care Health Inc. specializes in treatments for critical illnesses such as immune disorders, cancer, and chronic conditions, offering personalized care plans tailored to individual patient needs. This company is instrumental in the health services sector, bridging the gap between hospitals and home-based care, which is crucial for patient recovery and ongoing treatment. With a strong emphasis on clinical expertise and patient-focused care, Option Care Health Inc. stands out in the healthcare market, addressing the growing demand for specialty medications and the need for integrated healthcare solutions. Its services are essential for enhancing patient outcomes and managing complex health conditions outside traditional hospital settings.

CEO Mr. John Charles Rademacher · 8,000 employees · United States · https://optioncarehealth.com